Example: Heart Attack
Clinical Trials on Angioimmunoblastic T-cell Lymphoma
Total 258 results
-
NCT03853044RecruitingConditions: Angioimmunoblastic T-cell Lymphoma
-
NCT03273452Unknown statusConditions: Angioimmunoblastic T-cell Lymphoma
-
NCT03593018RecruitingConditions: Relapsed Angioimmunoblastic T-Cell Lymphoma; Refractory Angioimmunoblastic T-cell Lymphoma
-
NCT00169156CompletedConditions: Untreated T-cell Angioimmunoblastic Lymphoma
-
NCT00070291TerminatedConditions: Lymphoma
-
NCT00958854Unknown statusConditions: Lymphoma
-
NCT02273739CompletedConditions: Solid Tumor; Glioma; Angioimmunoblastic T-cell Lymphoma; Intrahepatic Cholangiocarcinoma; Chondrosarcoma
-
NCT04251065Not yet recruitingConditions: Refractory T-Cell Lymphoma; Relapsed T-Cell Lymphoma
-
NCT04319601RecruitingConditions: Angioimmunoblastic T-cell Lymphoma; Chemotherapy Effect; Chemotherapeutic Toxicity
-
NCT02520791RecruitingConditions: Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Recurrent Angioimmunoblastic T-Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma; Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Recurrent Mycosis Fungoides; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Angioimmunoblastic T-Cell Lymphoma; Refractory Grade 1 Follicular Lymphoma; Refractory Grade 2 Follicular Lymphoma; Refractory Grade 3a Follicular Lymphoma; Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Stage IB Mycosis Fungoides AJCC v7; Stage II Mycosis Fungoides AJCC v7; Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage III Mycosis Fungoides AJCC v7; Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage IV Mycosis Fungoides AJCC v7
-
NCT03070964TerminatedConditions: Lymphoma
-
NCT01553786CompletedConditions: T-cell Lymphoma
-
NCT03703375RecruitingConditions: Lymphoma, T-Cell
-
NCT03040206CompletedConditions: Peripheral T-Cell Lymphoma, Not Otherwise Specified; Angioimmunoblastic T-cell Lymphoma; Anaplastic Large Cell Lymphoma, ALK-negative
-
NCT03552692Active, not recruitingConditions: T-Cell Lymphoma Relapsed; T-Cell Lymphoma Refractory
-
NCT03590574RecruitingConditions: T Cell Non-Hodgkin Lymphoma; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Angioimmunoblastic T-cell Lymphoma; Anaplastic Large Cell Lymphoma
-
NCT01198665CompletedConditions: Peripheral T Cell Lymphoma Unspecified; Anaplastic Large Cell Lymphoma, ALK-negative; Angioimmunoblastic T Cell Lymphoma; Cutaneous T Cell Lymphoma
-
NCT00725231Unknown statusImmunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOPConditions: Peripheral T Cell Lymphoma, Unspecified; Angioimmunoblastic Lymphadenopathy; Extranodal NK/T-cell Lymphoma
-
NCT01336933CompletedConditions: Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Peripheral T-cell Lymphoma
-
NCT02223208RecruitingConditions: Peripheral T-cell Lymphomas (PTCL); PTCL-NOS; Angioimmunoblastic T-cell Lymphoma (AITL); ALK- Anaplastic Large Cell Lymphoma (ALCL); Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin
-
NCT01719835Active, not recruitingConditions: Peripheral T-cell Lymphoma NOS; Anaplastic Large Cell Lymphoma, ALK-Negative; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic Gamma/ Delta T-cell Lymphoma; Enteropathy-Associated T-Cell Lymphoma
-
NCT01336920CompletedConditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Peripheral T-cell Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma
-
NCT02561273Active, not recruitingConditions: Anaplastic Large Cell Lymphoma, ALK-Negative; Anaplastic Large Cell Lymphoma, ALK-Positive; Hepatosplenic T-Cell Lymphoma; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Stage II Angioimmunoblastic T-cell Lymphoma; Stage II Enteropathy-Associated T-Cell Lymphoma; Stage III Angioimmunoblastic T-cell Lymphoma; Stage III Enteropathy-Associated T-Cell Lymphoma; Stage IV Angioimmunoblastic T-cell Lymphoma; Stage IV Enteropathy-Associated T-Cell Lymphoma
-
NCT03598998RecruitingConditions: Anaplastic Large Cell Lymphoma; Nodal Peripheral T-Cell Lymphoma With TFH Phenotype; Recurrent Anaplastic Large Cell Lymphoma; Recurrent Angioimmunoblastic T-Cell Lymphoma; Recurrent Enteropathy-Associated T-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Hepatosplenic T-Cell Lymphoma; Recurrent Mature T- Cell and NK-Cell Non-Hodgkin Lymphoma; Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma; Recurrent Mycosis Fungoides; Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified; Refractory Anaplastic Large Cell Lymphoma; Refractory Angioimmunoblastic T-Cell Lymphoma; Refractory Enteropathy-Associated T-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Hepatosplenic T-Cell Lymphoma; Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Refractory Mycosis Fungoides; Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified; Subcutaneous Panniculitis-Like T-Cell Lymphoma
-
NCT03493451Active, not recruitingConditions: Peripheral T Cell Lymphoma; PTCL; Extranodal NK/T-cell Lymphoma; Extranodal NK/T-cell Lymphoma, Nasal Type; Extranodal NK T Cell Lymphoma; Extranodal NK T Cell Lymphoma, Nasal; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Angioimmunoblastic T-Cell Lymphoma Recurrent; Angioimmunoblastic T-Cell Lymphoma Refractory; Peripheral T-cell Lymphoma NOS; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Peripheral T-Cell Lymphoma Refractory; Anaplastic Large Cell Lymphoma; Anaplastic Large Cell Lymphoma, ALK-Positive; Anaplastic Large Cell Lymphoma, ALK-negative; ALK-negative Anaplastic Large Cell Lymphoma; ALK-Positive Anaplastic Large Cell Lymphoma; Cutaneous T-cell Lymphoma